Clinical Trials · NCT05520775
Semaglutide for Alcohol Use Disorder
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 48
- Start date
- Sep 2022
- Locations
- 1 site, United States
- Primary endpoint
- Change in Alcohol Consumed